|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Neurology & Neurosurgery and Medicine, McGill University, Montreal General Hospital, Montreal, Quebec, Canada.
Address correspondence and reprint requests to Dr. Ronald B. Postuma, Division of Neurology, L7-305 Montreal General Hospital, 1650 Cedar Ave., Montreal, Quebec, Canada H3G 1A4 ronald.postuma{at}mcgill.ca
Objective: Associations between peripheral neuropathy and restless legs syndrome (RLS) have been described, but have not been consistently reproduced. If RLS prevalence is truly increased by neuropathy, this has important implications for RLS pathophysiology.
Methods: In a case-control design, 245 patients with peripheral neuropathy and 245 age- and sex-matched controls were screened for RLS using a standardized phone questionnaire based on international RLS diagnostic criteria. All persons who answered yes to three of four criteria were considered screen-positive. All screen-positive patients underwent a confirmatory diagnostic evaluation by a movement disorders specialist blinded to the neuropathy status of the patient. RLS prevalence was calculated and compared using Fisher exact test.
Results: A total of 65 (26.5%) patients with neuropathy screened positive compared to 25 (10.2%) controls (p < 0.0001). However, the diagnosis was confirmed in only 46% of screen-positive patients with neuropathy, vs 80% of controls (p = 0.005). Cramps and paresthesia without true diurnal variation or rest exacerbation were the commonest causes of false-positive screens. After diagnostic confirmation, the overall prevalence of RLS did not differ between neuropathy patients and controls (12.2% vs 8.2%, p = 0.14). However, when classified by etiology, RLS was found in 14/72 (19.4%) patients with hereditary neuropathy, a prevalence higher than found in controls (p = 0.016) and acquired neuropathy (9.2%, p = 0.033). Among patients with neuropathy, those with RLS more commonly had a family history of RLS (37% vs 15%, p = 0.007) and were younger (49.9 vs 61.4, p = 0.0003).
Conclusions: Restless legs syndrome is more prevalent among patients with hereditary neuropathy, but not in those with acquired neuropathies.
CIDP = chronic inflammatory demyelinating polyneuropathy; GBS = Guillain-Barré syndrome; HMSN = hereditary motor sensory neuropathy; HSAN = hereditary sensory and autonomic neuropathy; IRLSSG = International Restless Legs Study Group; MGUS = monoclonal gammopathy of uncertain significance; NCS = nerve conduction studies; PPV = positive predictive value; RLS = restless legs syndrome.
Supplemental data at www.neurology.org
Editorial, page 950
e-Pub ahead of print on November 26, 2008, at www.neurology.org.
Supported by the Weston Foundation and by the Fonds de la recherche en santé du Québec.
Disclosure: The authors report no disclosures.
Received May 12, 2008. Accepted in final form August 29, 2008.
Related Article
Neurology 2009 72: 950-951.
This article has been cited by other articles:
![]() |
M. Pourfar and A. Feigin The numb and the restless: Peripheral neuropathy and RLS Neurology, March 17, 2009; 72(11): 950 - 951. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |